Successful long-term immunologic reconstitution by allogeneic hematopoietic stem cell transplantation cures patients with autosomal dominant hyper-IgE syndrome.
Goussetis
Evgenios
E
Peristeri
Ioulia
I
Kitra
Vasiliki
V
Traeger-Synodinos
Joanne
J
Theodosaki
Maria
M
Psarra
Katerina
K
Kanariou
Maria
M
Tzortzatou-Stathopoulou
Fotini
F
Petrakou
Eftichia
E
Fylaktou
Irene
I
Kanavakis
Emmanuel
E
Graphakos
Stelios
S
D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007589:Job Syndrome / Q000235:genetics / Q000628:therapy*; D008228:Lymphoma, Non-Hodgkin / Q000235:genetics / Q000628:therapy*; D008297:Male; D017354:Point Mutation; D011241:Prednisone / Q000008:administration & dosage; D012074:Remission Induction; D050796:STAT3 Transcription Factor / Q000235:genetics; D013997:Time Factors; D014184:Transplantation, Homologous; D014750:Vincristine / Q000008:administration & dosage
D050796:STAT3 Transcription Factor; C494086:STAT3 protein, human; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone